Comparison of Zolpidem Tartrate Extended-Release vs. Placebo in Treatment of Insomnia Associated With Newly Diagnosed Major Depressive Disorder (MDD) or Untreated MDD Relapse, When Used Concomitantly With Escitalopram

Trial Profile

Comparison of Zolpidem Tartrate Extended-Release vs. Placebo in Treatment of Insomnia Associated With Newly Diagnosed Major Depressive Disorder (MDD) or Untreated MDD Relapse, When Used Concomitantly With Escitalopram

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Dec 2010

At a glance

  • Drugs Zolpidem (Primary) ; Escitalopram
  • Indications Insomnia; Major depressive disorder
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 10 Jun 2008 Results presented at APSS 2008, according to a sanofi-aventis media release.
    • 05 Sep 2007 Status changed from in progress to completed.
    • 17 Jan 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top